National Healthcare (NHC) closed at $209.74 on November 9, 2026, up 0.4% from the previous close, on volume of 146,333 shares (30-day average 136,544).
Data as of November 9, 2026.
National Healthcare Non-GAAP EPS of $1.76, revenue of $407.9M
Seeking Alpha News (Fri, 6-Nov 7:41 AM ET)
NHC Reports Third Quarter 2026 Earnings
Business Wire (Fri, 6-Nov 7:30 AM ET)
National Healthcare declares $0.67 dividend
Seeking Alpha News (Thu, 5-Nov 10:30 PM ET)
Business Wire (Thu, 5-Nov 8:00 PM ET)
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
National Healthcare trades on the AMEX stock market under the symbol NHC.
As of November 10, 2026, NHC stock price was flat at $209.74 with 1,234 million shares trading.
NHC has a beta of -0.29, meaning it tends to be less sensitive to market movements. NHC has a correlation of 0.01 to the broad based SPY ETF.
NHC has a market cap of $3.28 billion. This is considered a Mid Cap stock.
In the last 3 years, NHC traded as high as $248.20 and as low as $70.50.
The top ETF exchange traded funds that NHC belongs to (by Net Assets): IJR, SDVY, VTI, IWM, VB.
NHC has outperformed the market in the last year with a return of +67.0%, while the SPY ETF gained +12.8%. In the last 3 month period, NHC beat the market returning -2.4%, while SPY returned -2.9%. However, in the most recent 2 weeks NHC has underperformed the stock market by returning -6.2%, while SPY returned -2.1%.
NHC support price is $203.32 and resistance is $216.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NHC shares will trade within this expected range on the day.
